Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents

医学 经皮冠状动脉介入治疗 阿司匹林 绝对风险降低 相对风险 内科学 心肌梗塞 传统PCI 随机对照试验 氯吡格雷 心脏病学 外科 置信区间
作者
Safi U. Khan,Maninder Singh,Shahul Valavoor,Muhammad U. Khan,Ahmad Naeem Lone,Muhammad Zia Khan,Muhammad Shahzeb Khan,Preethi Mani,Samir Kapadia,Erin D. Michos,Gregg W. Stone,Ankur Kalra,Deepak L. Bhatt
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:142 (15): 1425-1436 被引量:135
标识
DOI:10.1161/circulationaha.120.046308
摘要

Background: The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with drug-eluting stents remains uncertain. We compared short-term (<6-month) DAPT followed by aspirin or P2Y12 inhibitor monotherapy; midterm (6-month) DAPT; 12-month DAPT; and extended-term (>12-month) DAPT after percutaneous coronary intervention with drug-eluting stents. Methods: Twenty-four randomized, controlled trials were selected using Medline, Embase, Cochrane library, and online databases through September 2019. The coprimary end points were myocardial infarction and major bleeding, which constituted the net clinical benefit. A frequentist network meta-analysis was conducted with a random-effects model. Results: In 79 073 patients, at a median follow-up of 18 months, extended-term DAPT was associated with a reduced risk of myocardial infarction in comparison with 12-month DAPT (absolute risk difference, –3.8 incident cases per 1000 person-years; relative risk, 0.68 [95% CI, 0.54–0.87]), midterm DAPT (absolute risk difference, –4.6 incident cases per 1000 person-years; relative risk, 0.61 [0.45–0.83]), and short-term DAPT followed by aspirin monotherapy (absolute risk difference, –6.1 incident cases per 1000 person-years; relative risk, 0.55 [0.37–0.83]), or P2Y12 inhibitor monotherapy (absolute risk difference, –3.7 incident cases per 1000 person-years; relative risk, 0.69 [0.51–0.95]). Conversely, extended-term DAPT was associated with a higher risk of major bleeding than all other DAPT groups. In comparison with 12-month DAPT, no significant differences in the risks of ischemic end points or major bleeding were observed with midterm or short-term DAPT followed by aspirin monotherapy, with the exception that short-term DAPT followed by P2Y12 inhibitor monotherapy was associated with a reduced risk of major bleeding. There were no significant differences with respect to mortality between the different DAPT strategies. In acute coronary syndrome, extended-term in comparison with 12-month DAPT was associated with a reduced risk of myocardial infarction without a significant increase in the risk of major bleeding. Conclusions: The present network meta-analysis suggests that, in comparison with 12-month DAPT, short-term DAPT followed by P2Y12 inhibitor monotherapy reduces major bleeding after percutaneous coronary intervention with drug-eluting stents, whereas extended-term DAPT reduces myocardial infarction at the expense of more bleeding events.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大模型的应助被778采纳,获得10
刚刚
刚刚
1秒前
奋斗书竹发布了新的文献求助10
1秒前
2秒前
2秒前
乐乐乐发布了新的文献求助10
2秒前
斯文败类的应助被赵彬旭采纳,获得10
3秒前
充电宝的应助被猇会不会采纳,获得10
3秒前
傢誠发布了新的文献求助10
3秒前
耿春丽发布了新的文献求助10
4秒前
chiaoyin999发布了新的文献求助10
4秒前
4秒前
syvshc的应助被hansang采纳,获得10
4秒前
柠栀完成签到,获得积分10
4秒前
落俗完成签到,获得积分10
4秒前
4秒前
5秒前
无花果的应助被Yu采纳,获得10
6秒前
Voyager发布了新的文献求助10
6秒前
17826539164发布了新的文献求助10
6秒前
6秒前
苏苏苏发布了新的文献求助10
6秒前
华仔的应助被称心的蛟凤采纳,获得10
7秒前
gwgplmz完成签到,获得积分10
7秒前
LuckyYu发布了新的文献求助10
7秒前
小栩发布了新的文献求助10
7秒前
学术智子发布了新的文献求助10
8秒前
小蘑菇的应助被Drcai采纳,获得10
8秒前
9秒前
Maestro_S的应助被ddw采纳,获得150
9秒前
10秒前
希芜完成签到 ,获得积分10
10秒前
11秒前
WWL完成签到,获得积分10
11秒前
初景发布了新的文献求助10
12秒前
Samming发布了新的文献求助10
12秒前
留胡子的寄瑶完成签到,获得积分10
13秒前
1101592875的应助被psl采纳,获得10
14秒前
sc发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187612
求助须知:如何正确求助?哪些是违规求助? 9575734
关于积分的说明 21842594
捐赠科研通 7785476
什么是DOI,文献DOI怎么找? 3435073
关于科研通互助平台的介绍 2559478
邀请新用户注册赠送积分活动 2481952